Optimizing Active Surveillance.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27460354.
- Also identified by DOI 10.1016/j.eururo.2016.07.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Active surveillance is evolving as a management strategy for favorable-risk prostate cancer. Further study is needed to determine the safety of surveillance for specific subgroups of patients, and to clarify the role of genomic markers and image-guided biopsy.
Medical subject headings
- Prostatic Neoplasms
- Watchful Waiting